Prot #CRAD001Y24135: An Open-Label, Phase II, Single-Arm Study of Everolimus in Combination with Letrozole in the Treatment of Postmenopausal Women with Estrogen Receptor Positive HER2 Negative Metastatic or Locally Advanced Breast Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date9/22/124/15/18

Funding

  • Novartis Pharmaceuticals Corporation (Prot #CRAD001Y24135)